Site Title Goes Here

Shortcut Navigation:

Phthalates

STRONG VOICES

Janet Gray, Ph.D.
Janet Gray, Ph.D.

As author of our 2008 and 2010 State of the Evidence reports, Dr. Gray drives the science behind all our work.

LEARN MORE >
Printer Friendly

References, Clear Science

Scientific references for the Clear Science section of our website, previously published as the report, State of the Evidence: The Connection Between Breast Cancer and the Environment. Research and writing by Janet Gray, Ph.D. Parenthetical references from the science pages of our website are listed here in alphabetical order.

A   B   C   D   E   F   G   H   I   J   K   L   M

N   O   P   Q   R   S   T   U   V   W   X   Y   Z


A 

Acevedo, R., Parnell, P., Villanueva, H., Chapman, L., Gimenez, T., Gray, S., & Bladwin, W. (2005). The contribution of hepatic steroid metabolism to serum estradiol and estriol concentrations in nonylphenol treated MMTVneu mice and its potential effects on breast cancer incidence and latency. J Appl Toxicol, 25, 339–353.

Adam, B., Bardos, H., & Adany, R. (2005). Increased genotoxic susceptibility of breast epithelial cells to ethylene oxide. Mutation Res, 585, 120–126.

Adams, C., Brown, P., Morello-Frosch, R., Brody, J.G., Rudel, R., Zota, A., Dunagan, S., Tovar, J., & Patton, S. (2011). Disentangling the exposure experience: The roles of community context and report-back of environmental exposure data. J Health Soc  Behav 52, 180–196.

Adams, M., Dozier, A., Shore, R., Lipshultz, S., Schwartz, R., Constine, L., … Fisher, S. (2010). Breast cancer risk 55  years after irradiation for an enlarged thymus and its implications for early childhood medical irradiation today. Cancer Epidemiol Biomarkers Prev, 19, 48–58.

Adlercreutz, H. (2003). Phytoestrogens and breast cancer. J Steroid Biochem Mol Biol, 83, 113–118.

Ahlbom, A., Cardis, E., Green, A., Linet, M., Savitz, D., & Swerdlow, A. (2001). Review of the epidemiological literature on MF and health. Environ Health Persp, 109, 911–933.

Ahn, K. C., Zhao, B., Chen, J., Cherednichenko, G., Sanmarti, E., Denison, M. S., … Hammock, B. D. (2008). In vitro biologic activities of the antimicrobials triclocarban, its analogs, and triclosan in bioassay screens: Receptor-based bioassay screens. Environ Health Persp, 116(9), 1203–1210.

Åkesson, A., Julin, B., & Wolk, A. (2008). Long-term dietary cadmium intake and postmenopausal endometrial cancer incidence: A population-based prospective cohort study. Cancer Res, 68(15), 6435–6441.

Aksglaede, L., Juul, A., Leffers, H., Skakkebaek, N., & Andersson, A. (2006). The sensitivity of the child to sex steroids: possible impact of exogenous estrogens. Hum Reprod Update, 12, 341–349.

Al-Dobaib, S., & Mousa, H. (2009). Benefits and risks of growth promoters in animal production. J Food Agric Environ, 7, 202–208.

Alexander, B., Mandel, J., Baker, B., Burns, C., Bartels, M., Acquavella, J., & Gustin, C. (2007). Biomonitoring of 2,4-dichlorophenoxyacetic acid exposure and dose in farm families. Environ Health Persp, 115, 370–376.

Ali, I., Damdimopoulou, P., Stenius, U., Adamsson, A., Mäkelä, S. I., Åkesson, A., … Halldin, K. (2012). Cadmium-induced effects on cellular signaling pathways in the liver of transgenic estrogen reporter mice. Toxicol Sci, 127(1), 66–75.

Ali, I., Penttinen-Damdimopoulou, P. E., Mäkelä, S. I., Berglund, M., Stenius, U., Åkesson, A., … Halldin, K. (2010). Estrogen-like effects of cadmium in vivo do not appear to be mediated via the classical estrogen receptor transcriptional pathway. Environ Health Persp, 118(10), 1389–1394.

Allen, N., Roddam, A., Allen, D., Fentiman, I., Peto, J., Holly, J., … Silva, I. (2005). A prospective study of serum insulin-like growth factor-I (IGF-1), IGF-II, IGF-binding protein-3 and breast cancer risk. Br J Cancer, 92, 1283–1287.

Allmyr, M., Adolfsson-Erici, M., McLachlan, M., & Sandborgh-Englund, G. (2006). Triclosan in plasma and milk from Swedish nursing mothers and their exposure via personal care products. Sci Total Environ, 372, 87–93.

Althuis, M., Brogan, D., Coates, R., Daling, J., Gammon, M., Malone, K., … Brinton, L. (2003). Breast cancers among very young premenopausal women - United States. Cancer Causes Control, 14, 151–160.

Althuis, M., Dozier, J., Anderson, W., Devesa, S., & Brinton, L. (2005). Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol, 34, 405–412.

Altman, R., Morello-Frosch, R., Brody, J., Rudel, R., Brown, P., & Averick, M. (2008). Pollution comes home and gets personal: Women’s experience of household chemical exposure. J Health Soc Behav, 49, 417–434.

Ambrosone, C., Freudenheim, J., Graham, S., Marshall, J., Vena, J., Brasure, J., … Shields, P. (1996). Cigarette smoking, N-acetyltransferase 2 polymorphisms, and breast cancer risk. J Am Med Assoc, 276, 1494–1501.

Andersen, H., Vinggaard, A., Rasmussen, T., Gjermandsen, I., & Bonefeld-Jorgensen, E. (2002). Effects of currently used pesticides in assays for estrogenicity, androgenicity, and aromatase activity in vitro. Toxicol Appl Pharmacol, 179, 1–12.

Anderson, G. L., Chlebowski, R. T., Aragaki, A. K., Kuller, L. H., Manson, J. E., Gass, M., … Wactawski-Wende, J. (2012). Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women’s Health Initiative randomised placebo-controlled trial. Lancet Oncol, 13(5), 476–486.

Anderson, G., Limacher, M., Assaf, A., Bassford, T., Beresford, S., Black, H., … Wasserthell-Smoller, S. (2004). Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women’s Health Initiative randomized controlled study. J Am Med Assoc, 291, 1701–1712.

Anderson, H., & Wolff, M. (2000). Environmental contaminants in human milk. J Expos Anal Environ Epidemiol, 10, 755–760.

Anderson, W., Matsuno, R., Sherman, M., Lissowska, J., Gail, M., Brinton, L., … Garcia-Closas, M. (2007). Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions. Cancer Causes Control, 18, 439–447.

Andersson, P., Blom, A., Johannisson, A., Pesonen, M., Tysklind, M., Berg, A., … Norrgren, L. (1999). Assessment of PCBs and hydroxylated PCBs as potential xenoestrogens: In vitro studies based on MCF-7 cell proliferation and induction of vitellogenin in primary culture of rainbow trout hepatocytes. Arch Environ Contam Toxicol, 37, 145–150.

Andersson, T., Johansson, A., Hsieh, C., Cnattingius, S., & Lambe, M. (2009). Increasing incidence of pregnancy-associated breast cancer in Sweden. Obstet Gynecol, 114, 568–572.

Andreeva, V., Unger, J., & Pentz, M. (2007). Breast cancer among immigrants: a systematic review and new research directions. J Immigrant Minor, 9, 307–322.

Andres, S., Abraham, K., Appel, K. E., & Lampen, A. (2011). Risks and benefits of dietary isoflavones for cancer. Cr Rev Toxicol, 41(6), 463–506. 

Andrieu, N., Easton, D., Chang-Claud, J., Rookus, M., Brohet, R., Cardis, E., … Goldgar, D. (2006). Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the International BRCA1/2 Carrier Cohort Study: A report from EMBRACE, GEGNNEPSO, GEO-HEBON, and IBCCS Collaborators’ Group. J Clin Oncol, 24, 3361–3366.

Angerer, J., Bird, M., Burke, T., Doerrer, N., Needham, L., Robison, S., … Zenick, H. (2006). Strategic biomonitoring initiatives: Moving the science forward. Toxicol Sci, 93, 3–10.

Anjum, B., Singh, R. B., Verma, N., Singh, R., Mahdi, A. A., Singh, R. K., … Wilson, D. W. (2012). Associations of circadian disruption of sleep and nutritional factors with risk of cancer. Open Nutraceuticals J, 5(Suppl.1), 124–135.

Antoniou, C., Koukouraki, E., & Diamadopoulos, E. (2009). Analysis of selected pharmaceutical compounds and endocrine disruptors in municipal wastewater using solid-phase microextraction and gas chromatography. Water Environ Res, 81, 664–669.

Apelberg, B. J., Goldman, L. R., Calafat, A. M., Herbstman, J. B., Kuklenyik, Z., Heidler, J., … Witter, F. R. (2007). Determinants of fetal exposure to polyfluoroalkyl compounds in Baltimore, Maryland. Environ Sci Tech, 41(11), 3891–3897.

Apelberg, B. J., Witter, F. R., Herbstman, J. B., Calafat, A. M., Halden, R. U., Needham, L. L., & Goldman, L. R. (2007). Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ Health Persp, 115(11), 1670–1676.

Arnold, S., Klotz, D., Collins, B., Vonier, P., Guillette, L. J., & McLachlan, J. (1996). Synergistic activation of estrogen receptor with combinations of environmental chemicals. Science, 272, 1489–1492.

Aronson, K., Miller, A., Woolcott, C., Sterns, E., McCready, D., Lickley, L., … Weber, J. (2000). Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 9, 55–63.

Arslan, A., Zeleniuch-Jacquotte, A., Lukanova, A., Afanasyeva, Y., Katz, J., Levitz, M., … Toniolo, P. (2006). Effects of parity on pregnancy hormonal profiles across ethnic groups with a diverse incidence of breast cancer. Cancer Epidemiol Biomarkers Prev, 15, 2123–2130.

Asara, Y., Marchal, J. A., Bandiera, P., Mazzarello, V., Delogu, L. G., Sotgiu, M. A., … Madeddu, R. (2012). Cadmium influences the 5-Fluorouracil cytotoxic effects on breast cancer cells. Eur J Histochem, 56(1), 1–6.

Athar, M., Back, J., Kopelovich, L., Bickers, D., & Kim, A. (2009). Multiple molecular targets of resveratrol: anti-carcinogenic mechanisms. Arch Biochem Biophys, 486, 95–102.

Aubé, M., Larochelle, C., & Ayotte, P. (2011). Differential effects of a complex organochlorine mixture on the proliferation of breast cancer cell lines. Environ Res, 111(3), 337–347. 

Aylward, L.L., Kirman, C.R., Schoeny, R., Portier, C.J., & Hays, S.M. (2013). Evaluation of biomonitoring data from the CDC national exposure report in a risk assessment context: Perspectives across chemicals.  Envir Health Persp 121, 287–294.

Ayyanan, A., Laribi, O., Schuepbach-Mallepell, S., Schrick, C., Gutierrez, M., Tanos, T., … Brisken, C. (2011). Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number. Molecular Endocrinology, 25(11), 1915–1923.

B 

Baccarelli, A., & Bollati, V. (2009). Epigenetics and environmental chemicals. Curr Opin Pediatr, 21, 243–251.

Balakrishnan, B., Henare, K., Thorstensen, E. B., Ponnampalam, A. P., & Mitchell, M. D. (2010). Transfer of bisphenol A across the human placenta. Am J Obstet Gynecol, 202(4), 393.e1–7. 

Balazs, C.L., & Morello-Frosch, R. (2013). The three Rs: How community-based participatory research strengthens the rigor, relevance, and reach of science. Environ Justice 6, 9–16.

Ballard, T., Lagorio, S., De Angelis, G., & Verdecchia, A. (2000). Cancer incidence and mortality among flight personnel: A meta-analysis. Aviat Space Environ Med, 71, 216–224.

Balmain, A., & Harris, C. (2000). Carcinogenesis, in mouse and human cells: parallels and paradoxes. Carcinogenesis, 21, 371–377.

Band, P., Le, N., Fang, R., Deschamps, M., Gallagher, R.P., & Yang, P. (2000). Identification of occupational cancer risks in British Columbia: A population-based case-control study of 995 incident breast cancer cases by menopausal status, controlling for confounding factors. J Occup Environ Med 42, 284–310.

Band, P., Le, N., Fang, R., & Deschamps, M. (2002). Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer. Lancet, 360, 1033–1034.

Bandera, E. V., Chandran, U., Buckley, B., Lin, Y., Isukapalli, S., Marshall, I., … Zarbl, H. (2011). Urinary mycoestrogens, body size and breast development in New Jersey girls. Sci Total Environ, 409(24), 5221–5227. 

Barcellos-Hoff, M., Park, C., & Wright, E. (2005). Radiation and the microenvironment: Tumorogenesis and therapy. Nat Rev Cancer, 5, 867–875.

Barlow, B., Cory-Slechta, D., Richfield, E., & Thiruchelvam, M. (2007). The gestational environment and Parkinson’s disease: Evidence for neurodevelopmental origins of a neurodegenerative disease. Reprod Toxicol, 23, 457–470.

Barr, L., Metaxas, G., Harbach, C. A. J., Savoy, L. A., & Darbre, P. D. (2012). Measurement of paraben concentrations in human breast tissue at serial locations across the breast from axilla to sternum. J Appl Toxicol, 32(3), 219–232. 

Bauer, K., Brown, M., Cress, R., Parise, C., & Caggiano, V. (2007). Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: A population-based study from the California Cancer Registry. Cancer, 109, 1721–1728.

Beale, L., Hodgson, S., Abellan, J.J., LeFevre, S., & Jarup, L. (2010). Evaluation of spatial relationships between health and the environment: The rapid inquiry facility. Envir Health Persp 118, 1306–1312.

Beard, J. (2006). DDT and human health. Sci Total Environ, 355, 78–89.

Beiki, O., Hall, P., Ekbom, A., & Moradi, T. (2012). Breast cancer incidence and case fatality among 4.7 million women in relation to social and ethnic background: a population-based cohort study. Breast Cancer Res, 14(1), R5. 

Belli, P., Bellaton, C., Durand, J., Balleydier, S., Milhau, N., Mure, M., … Le Jan, C. (2010). Fetal and neonatal exposure to the mycotoxin zearalenone induces phenotypic alterations in adult rat mammary gland. Food Chem Toxicol, 48(10), 2818–2826. 

Belli, S., Comba, P., De Santis, M., Grignoli, M., & Sasco, A. (1992). Mortality study of workers employed by the Italian National Institute of Health, 1960-1989. Scand J Work Environ Health, 18, 64–67.

Bellinger, D. C. (2008). Lead neurotoxicity and socioeconomic status: conceptual and analytical issues. Neurotoxicology, 29(5), 828–832. 

Benbrahim-Tallaa, L., Tokar, E., Diwan, B., Dill, A., Coppin, J., & Waalkes, M. (2009). Cadmium malignantly transforms normal human breast epithelial cells into a basal-like phenotype. Environ Health Persp, 117, 1847–1852.

Bennett, M., & Davis, B. (2002). The identification of mammary carcinogens in rodent bioassays. Environ Mol Mutagenesis, 39, 150–157.

Benotti, M., Trenholm, R., Vanderford, B., Holady, J., Stanford, B., & Snyder, S. (2009). Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water. Environ Sci Technol, 43, 597–603.

Benzoni, E., Minervini, F., Giannoccaro, A., Fornelli, F., Vigo, D., & Visconti, A. (n.d.). Influence of in vitro exposure to mycotoxin zearalenone and its derivatives on swine sperm quality. Reprod Toxicol, 25, 461–467.

Beral, V. (2003). Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet, 362(9382), 419–427.

Bernholtz, S., Laitman, Y., Kaufman, B., Paluch Shimon, S., & Friedman, E. (2011). Cancer risk in Jewish BRCA1 and BRCA2 mutation carriers: Effects of oral contraceptive use and parental origin of mutation. Breast Cancer Res Tr, 129(2), 557–563.

Bernstein, L., Allen, M., Anton-Culver, H., Deapen, D., Horn-Ross, P., Peel, D., … Ross, R. (2002). High breast cancer incidence rates among California teachers: Results from the California Teachers. Study -  United States. Cancer Causes Control, 13, 625–635.

Berrington-de-Gonzalez, A., Berg, C., Visvanathan, K., & Robson, M. (2009). Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers. J Natl Cancer Inst, 101, 205–209.

Berrington-de-Gonzalez, A., Mahesh, M., & Kim, K.-P. (2009). Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med, 169, 2071–2077.

Betancourt AM, Eltoum IA, Desmond RA, Russo J, Lamartiniere CA (2011).  In utero exposure to bisphenol a shifts the window of susceptibility for mammary carcinogenesis in the rat.  Environmental Health Perspectives 119: 1614-1619.

Beyea, J., Stellman, S., Hatch, M., & Gammon, M. (2008). Airborne emissions from 1961 to 2004 of benzo(a)pyrene from U.S. vehicles per km of travel based on tunnel studies. Environ Sci Technol, 47, 7315–7320.

Bhatia, S., Yasui, Y., Robison, L., Birch, J., Bogue, M., Diller, L., … Meadows, A. (n.d.). High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin’s disease: report from the Late Effects Study Group. J Clin Oncol, 21, 4386–94.

Bhatti, P., Doody, M., Alexander, B., Yuenger, J., Simon, S., Weinstock, R., … Sigurdson, A. (2007). Breast cancer risk polymorphisms and interactions with ionizing radiation among U.S. radiologic technologists. Cancer Epidemiol Biomarkers Prev, 17, 2007–2011.

Bibbo, M., Gill, W., Azizi, F., Blough, R., Fang, V., Rosenfield, R., … Wied, G. (1977). Follow-up study of male and female offspring of DES-exposed mothers. Obstet Gynecol J, 49, 1–8.

Biglia, N., Sgro, L., Defabiani, E., De Rosa, G., Ponzone, R., Marenco, D., & Sismondi, P. (2005). The influence of hormone replacement therapy on the pathology of breast cancer. EJSO: J Cancer Surg, 31, 467–472.

Birnbaum, L., & Fenton, S. (2003). Cancer and developmental exposure to endocrine disruptors. Environ Health Persp, 111, 389–394.

Blask, D. (2009). Melatonin, sleep disturbance and cancer risk. Sleep Med Rev, 13, 257–264.

Blask, D., Brainard, G., Dauchy, R., Hanifin, J., Davidson, L., Krause, J., … Zalatan, F. (2005). Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res, 65, 11174–11184.

Blask, D. E., Hill, S. M., Dauchy, R. T., Xiang, S., Yuan, L., Duplessis, T., … Sauer, L. A. (2011). Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night. J Pineal Res, 51(3), 259–269. 

Boice, J. (2001). Radiation and breast carcinogenesis. Med & Pediatr Oncol, 36, 508–513.

Bonde, J. P., Hansen, J., Kolstad, H. A., Mikkelsen, S., Olsen, J. H., Blask, D. E., … Åkerstedt, T. (2012). Work at night and breast cancer - report on evidence-based options for preventive actions. Scand J Work Environ Health, 38(4), 380–390.

Bonefeld-Jorgensen, E.C., Long, M., Bossi, R., Ayotte, P., Asmund, G., Krüger, T., … Dewailly, E. (2011). Perfluorinated compounds are related to breast cancer risk in Greenlandic Inuit: A case control study. Environ Health-Glob, 10(1).

Bonefeld-Jorgensen, Eva C, Long, M., Bossi, R., Ayotte, P., Asmund, G., Krüger, T., … Dewailly, E. (2011). Perfluorinated compounds are related to breast cancer risk in Greenlandic Inuit: a case control study. Environ Health-Glob, 10, 88. 

Bonner, M., Han, D., Nie, J., Rogerson, P., Vena, J., Muti, P., … Freudenheim, J. (2005). Breast cancer risk and exposure in early life to polycyclic aromatic hydrocarbons using total suspended particulates as a proxy measure. Cancer Epidemiol Biomarkers Prev, 14, 53–60.

Borch, J., Axelstad, M., Vinggaard, A., Metzdorff, S., Brokken, L., & Dalgaard, M. (2006). Mechanisms underlying the anti-androgenic effects of diethylhexyl phthalate in fetal rat testis. Toxicol, 223, 144–155.

Borgquist, S., Anagnostaki, L., Jirstom, K., Landberg, G., & Manjer, J. (2007). Breast tumours following combined hormone replacement therapy express favorable prognostic factors. Int J Cancer, 120, 2202–2207.

Borrell, B. (2010). The big test for bisphenol A. Nature, 464, 1122–1124.

Borrell, L. N., Factor-Litvak, P., Wolff, M. S., Susser, E., & Matte, T. D. (2004). Effect of socioeconomic status on exposures to polychlorinated biphenyls (PCBs) and dichlorodiphenyldichloroethylene (DDE) among pregnant African-American women. Arch Environ Health, 59(5), 250–255. 

Boucher, B., Cotterchio, M., Krieger, N., & Thompson, L. (2008). Soy formula and breast cancer risk. Epidemiology, 19, 165–168.

Bourguignon, J., Rasier, G., Lebrethon, M., Gerard, A., Naveau, E., & Parent, A. (2010). Neuroendocrine disruption of pubertal timing and interactions between homeostasis of reproduction and energy balance. Mol Cell Endocrinol, 324, 110–120.

Bowen, R., Stebbing, J., & Jones, L. (2006). A review of the ethnic differences in breast cancer. Pharmacogenomics, 7, 935–942.

Braathen, M., Mortensen, A., Sandvik, M., Skare, J., & Arukwe, A. (2009). Estrogenic effects of selected hydroxy polychlorinated biphenyl congeners in primary culture of Atlantic salmon (Salmo salar) hepatocytes. Arch Environ Contam Toxicol, 56, 111–122.

Bradbury, A. R., & Olopade, O. I. (2007). Genetic susceptibility to breast cancer. Rev Endocr Metab Dis, 8(3), 255–267.

Bradley, E., Boughtflower, V., Smith, T., Speck, D., & Castle, L. (2005). Survey of the migration of melamine and formaldehyde from melamine food contact articles available on the UK market. Food Addit Contam, 22, 597–606.

Brama, M., Gnessi, L., Basciani, S., Cerulli, N., Politi, L., Spera, G., … Migilaccio, S. (2007). Cadmium induces mitogenic signaling in breast cancer cell by an Eralpha-dependent mechanism. Mol Cell Endocrinol, 264, 102–108.

Brand, J. S., Chan, M.-F., Dowsett, M., Folkerd, E., Wareham, N. J., Luben, R. N., … Khaw, K.-T. (2011). Cigarette smoking and endogenous sex hormones in postmenopausal women. J Clin Endocr Metab, 96(10), 3184–3192. 

Brand, R., McMahon, L., Jendrzejewski, J., & Charron, A. (2007). Transdermal absorption of the herbicide 2,4-dichlorophenoxyacetic acid is enhanced by both ethanol consumption and sunscreen application. Food Chem Toxicol, 45, 93–97.

Braun, J. M., Kalkbrenner, A. E., Calafat, A. M., Yolton, K., Ye, X., Dietrich, K. N., & Lanphear, B. P. (2011). Impact of early-life bisphenol A exposure on behavior and executive function in children. Pediatrics, 128(5), 873–882. 

Braun, J. M., Yolton, K., Dietrich, K. N., Hornung, R., Ye, X., Calafat, A. M., & Lanphear, B. P. (2009). Prenatal bisphenol A exposure and early childhood behavior. Environ Health Persp, 117(12), 1945–1952. 

Braun, J., Yolton, K., Dietrich, K., Hornung, R., Ye, X., Calafat, A., & Lanphear, B. (2009). Prenatal bisphenol A exposure and early childhood behavior. Environ Health Persp, 117, 1945–1952.

Braun, L., Fausto-Sterling, A., Fullwiley, D., Hammonds, E. M., Nelson, A., Quivers, W., … Shields, A. E. (2007). Racial categories in medical practice: how useful are they? PLoS Med, 4(9), e271. 

Brausch, J. M., & Rand, G. M. (2011). A review of personal care products in the aquatic environment: Environmental concentrations and toxicity. Chemosphere, 82(11), 1518–1532.

Brenner, D., Doll, R., Goodhead, D., Hall, E., Land, C., Little, J., … Zaider, M. (2003). Cancer risks attributable to low doses of ionizing radiation. Proc Natl Acad Sci, 100, 13761–13766.

Brenner, D. J. (2011). Are x-ray backscatter scanners safe for airport passenger screening? For most individuals, probably yes, but a billion scans per year raises long-term public health concerns. Radiology, 259(1), 6–10. 

Brinton, L., Scoccia, B., Moghissi, K., Westhoff, C., Althuis, M., Mabie, J., & Lamb, E. (2004). Breast cancer risk associated with ovulation-stimulating drugs. Hum Reprod, 19, 2005–2013.

Brody, J., Aschengrau, A., McKelvey, W., Rudel, R., Swartz, C., & Kennedy, T. (2004). Breast cancer risk and historical exposure to pesticides from wide-area applications assessed with GIS. Environ Health Persp, 112, 889–897.

Brody, J., Morello-Frosch, R., Zota, A., Brown, P., Perez, C., & Rudel, R. (2009). Linking exposure assessment science with policy objectives for environmental justice and breast cancer advocacy: The Northern California Household Exposure Study. Am J Public Health, 99, 600–609.

Brody, J., Moysich, K., Humblet, O., Attfield, K., Beehler, G., & Rudel, R. (2007). Environmental pollutants and breast cancer. Epidemiol Stud Cancer, 109, 2667–2711.

Brody, J. G., & Rudel, R. A. (2003). Environmental pollutants and breast cancer. Environ Health Persp, 111(8), 1007–1019.

Brody, J., Rudel, R., Melly, S., & Maxwell, N. (1998). Endocrine disruptors and breast cancer. Forum Appl Res Public Policy, 13, 24–31.

Broeks, A., Braaf, L. M., Wessels, L. F. A., Van de Vijver, M., De Bruin, M. L., Stovall, M., … Van ’t Veer, L. J. (2010). Radiation-Associated Breast Tumors Display a Distinct Gene Expression Profile. Int J Radiat Oncol, 76(2), 540–547.

Brophy, J., Keith, M., Gorey, K., Luginaah, I., Laukkanen, E., Hellyer, D., … Gilbertson, M. (2006). Occupation and breast cancer: A Canadian case-control study. Ann NY Acad Sci, 1076, 765–777.

Brophy JR, Keith MM, Watterson A, Park R, Gilbertson M, Maticka-Tyndale E, Beck M, Abu-Zahra, Schneider K, Reinhartz A, DeMatteo R, Luginaah I (2012). Breast cancer risk in relation to occupations with exposure to carcinogens and endocrine disruptors: a Canadian case–control study. Environ Health. 2012; 11: 87. Published online 2012 November 19. doi: 10.1186/1476-069X-11-87.

Brotons, J., Olea-Serrano, M., Villalobos, M., Pedraza, V., & Olea, N. (1995). Xenoestrogens released from lacquer coatings in food cans. Environ Health Persp, 103, 608–612.

Brown, N., Manzolillo, P., Zhang, J., Wang, J., & Lamartiniere, C. (1998). Prenatal TCDD and predisposition to mammary cancer in rats. Carcinogenesis, 19, 1623–1629.

Brulle, R., & Pellow, D. (2006). Environmental justice: human health and environmental inequalities. Ann Rev Public Health, 27, 103–124.

Bruner Huber, L., & Huber, K. (2009). Contraceptive choices of women 35-44 years of age: Findings from the behavioral risk factor surveillance system. Ann Epidemiol, 19, 823–833.

Byford, J., Shaw, L., Drew, M., Pope, G., Sauer, M., & Darbre, P. (2002). Oestrogenic activity of parabens in MCF7 human breast cancer cells. J Steroid Biochem Mol Biol, 80, 49–60.

Byrne, C., Divekar, S., Storchan, G., Parodi, D., & Martin, M. (2009). Cadmium: a metallohormone. Toxicol Appl Pharmacol, 238, 266–271.

C

Caan, B. J., Natarajan, L., Parker, B., Gold, E. B., Thomson, C., Newman, V., … Pierce, J. P. (2011). Soy food consumption and breast cancer prognosis. Cancer Epidem Biomar, 20(5), 854–858. 

Calabrese, E. (2004). Hormesis: from marginalization to mainstream. A case for hormesis as the default dose-response model in risk assessment. Toxicol Pharmacol, 197, 125–136.

Calabrese, E., Staudenmayer, J., Stanek, E., & Hoffmann, G. (2006). Hormesis outperforms threshold model in National Cancer Institute antitumor drug screening database. Toxicol Sci, 94, 368–378.

Calaf, G., & Hei, T. (2000). Establishment of a radiation- and estrogen-induced breast cancer model. Carcinogenesis, 21, 769–776.

Calaf, G. M., & Garrido, F. (2011). Catechol estrogens as biomarkers for mammary gland cancer. Int J Oncol, 39(1), 177–183.

Calafat, A. M., Wong, L.-Y., Silva, M. J., Samandar, E., Preau Jr., J. L., Jia, L. T., & Needham, L. L. (2011). Selecting adequate exposure biomarkers of diisononyl and diisodecyl phthalates: Data from the 2005-2006 national health and nutrition examination survey. Environ Health Persp, 119(1), 50–55.

Calafat, A. M., Ye, X., Wong, L.-Y., Bishop, A. M., & Needham, L. L. (2010). Urinary concentrations of four parabens in the U.S. Population: NHANES 2005-2006. Environ Health Persp, 118(5), 679–685.

Calafat, A., Weuve, J., & Ye, X. (2009). Exposure to bisphenol A and other phenols in neonatal intensive care unit premature infants. Environ Health Persp, 117, 639–644.

Calafat, A., Ye, X., Wong, L.-Y., JA, R., & LL, N. (2008). Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol. Environ Health Persp, 116, 2003–2004.

Calafat, AM., Kuklenyik, Z., Reidy, J., Caudill, S., Ekong, J., & Needham, L. (2005). Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Persp, 113, 391–395.

Calderon-Margalit, R., Friedlander, Y., Yanetz, R., Kleinhaus, K., Perrin, M. C., Manor, O., … Paltiel, O. (2009a). Cancer risk after exposure to treatments for ovulation induction. Am J Epidemiol, 169(3), 365–375.

Calderon-Margalit, R., Friedlander, Y., Yanetz, R., Kleinhaus, K., Perrin, M., Manor, O., … Paltiel, O. (2009b). Cancer risk after exposure to treatments for ovulation induction. Am J Epidemiol, 169, 365–375.

Calle, E., Miracle-McMahill, H., Thun, M., & Heath, C. (1994). Cigarette smoking and risk of fatal breast cancer. Am J Epidemiol, 139, 1001–1007.

Calvo, V., & Beato, M. (2011a). BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters. Cancer Res, 71(9), 3422–3431.

Calvo, V., & Beato, M. (2011b). BRCA1 Counteracts Progesterone Action by Ubiquitination Leading to Progesterone Receptor Degradation and Epigenetic Silencing of Target Promoters. Cancer Res, 71(9), 3422–3431. 

Cameron, H., & Foster, W. (2009). Developmental and lactational exposure to dieldrin alters mammary tumorigenesis in her2/neu transgenic mice. Plos One, 4, 4303.

Campagnoli, C., Abbà, C., Ambroggio, S., & Peris, C. (2005). Pregnancy, progesterone and progestins in relation to breast cancer risk. J Steroid Biochem, 97(5), 441–450. 

Campbell, R. T., Li, X., Dolecek, T. A., Barrett, R. E., Weaver, K. E., & Warnecke, R. B. (2009). Economic, racial and ethnic disparities in breast cancer in the US: Towards a more comprehensive model. Health Place, 15(3), 855–864.

Canales-Aguirre, A., Padilla-Camberos, E., Gómez-Pinedo, U., Salado-Ponce, H., Feria-Velasco, A., & De Celis, R. (2011). Genotoxic effect of chronic exposure to DDT on lymphocytes, oral mucosa and breast cells of female rats. Int J Environ Res Public Health, 8(2), 540–553. 

Cantor, K., Stewart, P., Brinton, L., & Dosemeci, M. (1995). Occupational exposures and female breast cancer mortality in the United States. J Occup Environ Med, 37, 336–348.

Carey, L., Perou, C., & Livasy, C. (2006). The poor prognosis basal-like breast cancer subtype is over-represented in young African-American women. J Am Med Assoc, 7, 2492–2502.

Carlin DJ,  Rider CV,  Woychik R,  Birnbaum LS (2012). Unraveling the Health Effects of Environmental Mixtures: An NIEHS Priority. Environ Health Perspect 120:a6–a8 (2013). 

Carpenter, D. (2010). Electromagnetic fields and cancer: The cost of doing nothing. Rev Envir Health, 25, 75–80.

Carwile, J., Luu, H., Bassett, L., Driscoll, D., Yuan, C., Chang, J., … Michels, K. (2009). Polycarbonate use and urinary bisphenol A concentrations. Environ Health Persp, 117, 1368–1372.

Cassidy, R., Natarajan, S., & Vaughan, G. (2005). The link between the insecticide heptachlor epoxide, estradiol, and breast cancer. Breast Cancer Res Treat, 90, 55–64.

CDC, C. for D. C. and P. (2007). Decline in breast cancer incidence: United States. Morbid Mortal Weekly Rep, 56, 549–553.

CDC: Center for Disease Control and Prevention. (n.d.). Third National Report on Human Exposure to Environmental Chemicals. Atlanta: Center for Disease Control and Prevention.

Cederroth, C., & Nef, S. (2009). Soy, phytoestrogens and metabolism: a review. Mol Cell Endocrinol, 304, 30–42.

CGHFBC, C. G. on H. F. in B. C. (1996). Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet, 347, 1713–1727.

CGHFBC, C. G. on H. F. in B. C. (1997). Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet, 350, 1047–1059.

Chagas, C. E. A., Rogero, M. M., & Martini, L. A. (2012). Evaluating the links between intake of milk/dairy products and cancer. Nutr Rev, 70(5), 294–300. 

Chan, M., Lu, X., Merchant, F., Iglehart, J., & Miron, P. (2005). Gene expression profiling of NMU-induced rat mammary tumors: cross species comparison with human breast cancer. Carcinogenesis, 26, 1343–1353.

Chang, Y., Tai, C., Lin, R., Yang, S., Chen, C., Shih, T., & Liou, S. (2003). A proportionate cancer morbidity ratio study of workers exposed to chlorinated organic solvents in Taiwan. Ind Health, 41, 77–87.

Charlier, C., Albert, A., Zhang, L., Dubois, N., & Plomteux, G. (2004). Polychlorinated biphenyls contamination in women with breast cancer. Clin Chim Acta, 347, 177–181.

Chen, J., Wang, S., Yu, H., Liao, P., & Lee, C. (2006). Body burden of dioxins and dioxin-like polychlorinated biphenyls in pregnant women residing in a contaminated area. Chemosphere, 65, 1667–1677.

Chen, Y.-J., Hung, C.-M., Kay, N., Chen, C.-C., Kao, Y.-H., & Yuan, S.-S. (2012). Progesterone receptor is involved in 2,3,7,8-tetrachlorodibenzo-p-dioxin-stimulated breast cancer cells proliferation. Cancer Lett, 319(2), 223–231. 

Chen, Z., An, Y., Wang, Z., Zhang, B., & Liu, L. (2007). Tobacco-specific carcinogen 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone (NNK) activating ERK1/2 MAP kinases and stimulating proliferation of human mammary epithelial cells. Chem Res Chin Univ, 23, 76–80.

Chiam, K., Tilley, W., Butler, L., & Bianco-Miotto, T. (2009). The dynamic and static modification of the epigenome by hormones: A role in the developmental origin of hormone related cancers. Biochim Biophys Acta, 1795, 104–109.

Chiazze, L., & Ference, L. (1981). Mortality among PVC fabricating employees. Environ Health Persp, 41, 137–143.

Chiu, C.G., Mitchell, T.L., & Fitch, M.I. (2013). From patient to participant: Enhancing the validity and ethics of cancer research through participatory research. J Cancer Educ 28, 237–246.

Choe, S.-Y., Kim, S.-J., Kim, H.-G., Lee, J. H., Choi, Y., Lee, H., & Kim, Y. (2003). Evaluation of estrogenicity of major heavy metals. Sci Total Environ, 312(1-3), 15–21.

Choi, A., Levy, J., Dockery, D., Ryan, L., Tolbert, P., Altshul, L., & Korrick, S. (2006). Does living near a Superfund site contribute to higher polychlorinated biphenyl (PCB) exposure? Environ Health Persp, 114, 1092–1098.

Chou, W.-C., Chen, J.-L., Lin, C.-F., Chen, Y.-C., Shih, F.-C., & Chuang, C.-Y. (2011). Biomonitoring of bisphenol A concentrations in maternal and umbilical cord blood in regard to birth outcomes and adipokine expression: a birth cohort study in Taiwan. Environ Health-Glob, 10, 94. 

Chou, Y., Huang, P., Lee, C., Wu, M., & Lin, S. (2009). Phthalate exposure in girls during early puberty. J Pediatr Endocrinol Metab, 22, 69–77.

Christen, V., Crettaz, P., Oberli-Schrämmli, A., & Fent, K. (2010). Some flame retardants and the antimicrobials triclosan and triclocarban enhance the androgenic activity in vitro. Chemosphere, 81(10), 1245–1252.

Cirillo, D., Rachiglio, A. M., La Montagna, R., Giordano, A., & Normanno, N. (2008). Leptin signaling in breast cancer: an overview. J Cell Biochem, 105(4), 956–964. 

Cirillo, T., Fasano, E., Castaldi, E., Montuori, P., & Amodio Cocchieri, R. (2011). Children’s exposure to Di(2-ethylhexyl)phthalate and dibutylphthalate plasticizers from school meals. J Agr Food Chem, 59(19), 10532–10538. 

Clavel-Chapelon, F., & E3N-EPIC Group. (2002). Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women. Br J Cancer, 86, 723–727.

Clemons, M., Loijens, L., & Goss, P. (2000). Breast cancer risk following irradiation for Hodgkin’s disease. Cancer Treat Rev, 26, 291–300.

Cohen, A., Lopez, A., Malloy, N., & Morello-Frosch, R. (2012). Our environment, our health: A community-based participatory environmental health survey in Richmond, California. Health Educ Behav 39, 198–209.

Cohn, B. A. (2011). Developmental and environmental origins of breast cancer: DDT as a case study. Reprod Toxicol, 31(3), 302–311. 

Cohn, B., Wolff, M., Cirillo, P., & Sholtz, R. (2007). DDT and breast cancer in young women: New data on the significance of age at exposure. Environ Health Persp, 115, 1406–1414.

Colditz, G., Hankinson, S., Hunter, D., Willet, W., Manson, J., Stampfer, M., … Speizer, F. (1995). The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med, 332, 1589–1593.

Cole LW and Foster SR (2001). From the Ground Up: Environmental Racism and the Rise of the Environmental Justice Movement. New York, NY: New York University Press.

Collier, R., Miller, M., Hildebrandt, J., Torkelson, A., White, T., Madsen, K., … Lanza, G. (1991). Factors affecting insulin-like growth factor-I concentration in bovine milk. J Dairy Sci, 74, 2095–2911.

Collier, R., Miller, M., McLaughlin, C., Johnson, H., & Baile, C. (2008). Effects of recombinant bovine somatotropin (rbST) and season on plasma and milk insulin-like growth factors I (IGF-I) and II (IGF-II) in lactating dairy cows. Domest Anim Endocrinol, 35, 16–23.

Collins, J., Bodner, K., Burns, C., Budinsky, R., Lamparski, L., Wilken, M., … Carson, M. (2007). Body mass index and serum chlorinated dibenzo-p-dioxin and dibenzofuran levels. Chemosphere, 66, 1079–1085.

Colton, T., Greenberg, E., Noller, K., Ressequie, L., Van Bennekom, C., Heeren, T., & Zhang, Y. (1993). Breast cancer in mothers prescribed diethylstilbestrol in pregnancy. Further follow-up. J Am Med Assoc, 269, 2096–2100.

Conde, J., Silva, S., Azevedo, A., Teixeira, V., Pina, J., Rueff, J., & Gaspar, J. (2009). Association of common variants in mismatch repair genes and breast cancer susceptibility: a multigene study. BioMed Cent, 9, 344.

Connor, K., Ramamoorthy, K., Moore, M., Mustain, M., Chen, I., Safe, S., … Balaquer, P. (1997). Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: Structure-activity relationships. Toxicol Appl Pharmacol, 145, 111–123.

Constantinou, A., White, B., Tonetti, D., Yang, Y., Liang, W., Li, W., & Van Breemen, R. (2005). The soy isoflavone daidzein improves the capacity of tamoxifen to prevent mammary tumors. Eur J Cancer, 41, 647–654.

Coogan, P., Clapp, R., Newcomb, P., Wenzl, T., Bogdan, G., Mittendorf, R., … Longnecker, M. (1996). Occupational exposure to 60-hertz magnetic fields and risk of breast cancer in women. Epidemiology, 7, 459–464.

Cooper, R., Stoker, T., Tyrey, L., Goldman, J., & McElroy, W. (2000). Atrazine disrupts the hypothalamic control of pituitary-ovarian function. Toxicol Sci, 53, 297–307.

Cos, S., & Sanchez-Barcelo, E. (2000). Melatonin and mammary pathological growth. Front Neuroendocrinol, 21, 133–170.

Costa, G., Haus, E., & Stevens, R. (2010). Shift work and cancer: considerations on rationale, mechanisms, aand epidemiology. Scand J Environ Health, 36, 163–179.

Costa, L., & Giordano, G. (2007). Developmental neurotoxicity of polybrominated diphenyl ether (PBDE) flame retardants. Neurotoxicology, 28, 1047–1067.

Costa, L., Giordano, G., Tagliaferri, S., Caglieri, A., & Mutti, A. (2008). Polybrominated diphenyl ether (PBDE) flame retardants: environmental contamination, human body burden and potential adverse health effects. ACTA Biomed, 79, 172–183.

Costantini, A., Gorini, G., Consonni, D., Miligi, L., Giovannetti, L., & Quinn, M. (2009). Exposure to benzene and risk of breast cancer among shoe factory workers in Italy. Tumori, 95, 8–12.

Cui, Y., Miller, A., & Rohan, T. (2006). Cigarette smoking and breast cancer risk: update of a prospective cohort study. Breast Cancer Res Treat, 100, 293.

Curl, C., Fenske, R., & Elgethun, K. (2003). Organophosphorus pesticide exposure of urban and suburban preschool children with organic and conventional diets. Environ Health Persp, 111, 377–82.

Curwin, B., Hein, M., Sanderson, W., Nishioka, M., Reynolds, S., Ward, E., & Alavanja, M. (2005). Pesticide contamination inside farm and nonfarm homes. J Occup Environ Hygiene, 2, 357–367.

D 

Daewood, S., & Cristofanilli, M. (2007). What progress have we made in managing inflammatory breast cancer. Oncology, 21, 673–685.

Dai, Q., Liu, B., & Du, Y. (2009). Meta-analysis of the risk factors of breast cancer concerning reproductive factors and oral contraceptive use. Front Med China, 3, 452–458.

Dairkee, S., Seok, J., Champion, S., Sayeed, A., Mindrinos, M., Xiao, W., … Goodson, W. (2008). Bisphenol A induces a profile of tumor aggressiveness in high-risk cells from breast cancer patients. Cancer Res, 68, 2076–2080.

Dann, A. B., & Hontela, A. (2011). Triclosan: Environmental exposure, toxicity and mechanisms of action. J Appl Toxicol, 31(4), 285–311.

Darbre, P., Aljarrah, A., & Miller, W. (2004). Concentrations of parabens in human breast tumours. J Appl Toxicol, 24, 5–13.

Darbre, P. D., & Harvey, P. W. (2008). Paraben esters: review of recent studies of endocrine toxicity, absorption, esterase, and discussion of possible health risks. J Appl Toxicol, 28, 561–578.

Darbre, P., & Harvey, P. (2008). Paraben esters review of recent studies of endocrine toxicity, absorption, esterase, and discussion of possible health risks. J Appl Toxicol, 28, 561–578.

Darnerud, P., Eriksen, G., Johannesson, T., Larsen, P., & Viluksela, M. (2001). Polybrominated diphenyl ethers: occurance, dietary exposure and toxicology. Environ Health Persp, 109, 49–68.

Davis, D., Bradlow, H., Wolff, M., Woodruff, T., Hoel, D., & Antonculver, H. (1993). Medical hypothesis: Xenoestrogens as preventable causes of breast cancer. Environ Health Persp, 101, 371–377.

Davis, F., Lin, H., Luidens, M., Zhou, M., & Mousa, S. (2009). Similar and shared nongenomic mechanisms of action of estrogen and thyroid hormone. Immunol Endocr Metab Agents Med Chem, 9, 84–89.

Daxenberger, A., Breier, B., & Sauerwein, H. (1998). Increased milk levels of insulin-like growth factor 1 (IGF-1) for the identification of bovine somatotropin (bST) treated cows. Analyst, 123, 2429–2435.

De Hond, E., & Schoeters, G. (2006). Endocrine disruptors and human puberty. Int J Androl, 29, 264–271.

De los Santos, J., & Buchholz, T. (2000). Carcinogenesis of the male breast. Curr Treat Options Oncol, 1, 221–227.

De Votcht, F., Sobala, W., Wilcyznska, U., Kromhout, H., & Szeszenia-Dabrowska, N. (2009). Cancer mortality and occupational exposure to aromatic amines and inhalable aerosols in rubber tire manufacturing in Poland. Cancer Epidemiol, 33, 94–102.

De Wit, C. (2002). An overview of brominated flame retardants in the environment. Chemosphere, 46, 583–624.

Deardorff, J., Fyfe, M., Ekwaru, J. P., Kushi, L. H., Greenspan, L. C., & Yen, I. H. (2012). Does neighborhood environment influence girls’ pubertal onset? Findings from a cohort study. BMC Pediatr, 12, 27. 

DeBruin, L., & Josephy, P. (2002). Perspives on the chemical etiology of breast cancer. Environ Health Persp, 110, 119–128.

DeBruin, L., Pawliszyn, J., & Josephy, P. (1999). Detection of monocyclic aromatic amines, possible mammary carcinogens, in human milk. Chem Res Toxciol, 12, 78–82.

Decastro, B., Korrick, S., Spengler, J., & Soto, A. (2006). Estrogenic activity of polychlorinated biphenyls present in human adipose tissue and the environment. Environ Sci Technol, 40, 2819–2825.

Del Valle, J., Feliubadalo, L., Nadal, M., Teule, A., Miro, R., Cuesta, R., … Lazaro, C. (2009). Identification and comprehensive characterization of large genomic rearrangements in the BRCA1 and BRCA2 genes. Breast Cancer Res Treat, 122, 733–743.

Delort, L., Kwiatkowski, F., Chalabi, N., Satih, S., Bignon, Y., & Bernard-Gallon, D. (2007). Risk factors for early age at breast cancer onset: The “COSA Program” population based study. Anticancer Res, 27, 1087–1094.

DeSantis, C., Howlader, N., Cronin, K. A., & Jemal, A. (2011). Breast cancer incidence rates in U.S. women are no longer declining. Cancer Epidem Biomar, 20(5), 733–739. 

Dewan, M., Ahmed, A., Iwasaki, Y., Ohba, K., Toi, M., & Yamamoto, N. (2006). Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer. Biomed & Pharmacother, 60, 273–276.

Diamanti-Kandarakis, E. (2009). Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement. Endocr Rev, 30, 293–342.

Dich, J., Zahm, S., Hanberg, A., & Adami, H. (1997). Pesticides (heptachlor) and cancer. Cancer Causes Control, 8, 420–443.

Dip, R., Buterin, T., Wenger, D., Schmid, P., & Naegeli, H. (2008). Genetic reprogramming of human mammary cells by environmental carcinogens released into breast milk. Chimia, 62, 410–416.

Dip, R., Lenz, S., Gmuender, H., & Naegeli, H. (2009). Pleiotropic combinatorial transcriptomes of human breast cancer cells exposed to mixtures of dietary phytoestrogens. Food Chem Toxicol, 47, 787–795.

Doerge, D. R., Twaddle, N. C., Vanlandingham, M., & Fisher, J. W. (2011). Pharmacokinetics of bisphenol A in neonatal and adult CD-1 mice: inter-species comparisons with Sprague-Dawley rats and rhesus monkeys. Toxicol Lett, 207(3), 298–305. 

Donaldson, S. G., Van Oostdam, J., Tikhonov, C., Feeley, M., Armstrong, B., Ayotte, P., … Shearer, R. G. (2010). Environmental contaminants and human health in the Canadian Arctic. Science of the Total Environment, 408(22), 5165–5234.

Dong, J.-Y., Zhang, L., He, K., & Qin, L.-Q. (2011). Dairy consumption and risk of breast cancer: a meta-analysis of prospective cohort studies. Breast Cancer Res Tr, 127(1), 23–31. 

Donovan, M., Tiwary, C., Axelrod, D., Sasco, A., Jones, L., Hajek, R., … Davis, D. (2007). Personal care products that contain estrogens or xenoestrogens may increase breast cancer risk. Med Hypotheses, 68, 756–766.

Doody, M., Freedman, D., Alexander, B., Hauptmann, M., Miller, J., Rao, R., … Linet, M. (2006). Breast cancer incidence in U.S. radiologic technologists. Cancer, 106, 2707–2715.

Doody, M., Lonstein, J., Stovall, M., Hacker, D., Luckyanov, N., & Land, C. (2000). Breast cancer mortality after diagnostic radiography: Findings from the U.S. Scoliosis Cohort Study. Spine, 25, 2052–2063.

Dos Santos Silva, I., Wark, P., McCormack, V., Mayer, D., Overton, C., Little, V., … MacLean, A. (2009). Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort. Br J Cancer, 100, 1824–1831.

Dosemeci, M., & Blair, A. (1994). Occupational cancer mortality among women employed in the telephone industry. J Occup Med, 36, 1204–1209.

Draelos, Z. (2005). Topical and oral estrogens revisited for antiaging purposes. Fertil Steril, 84, 291–292.

Drost, R., & Jonkers, J. (2009). Preclinical mouse models for BRCA1–associated breast cancer. Br J Cancer, 101, 1651–1657.

Du, M., Yang, X., Hartman, J. A., Cooke, P. S., Doerge, D. R., Ju, Y. H., & Helferich, W. G. (2012). Low-dose dietary genistein negates the therapeutic effect of tamoxifen in athymic nude mice. Carcinogenesis, 33(4), 895–901.

Dumeaux, V., Borresen-Dale, A., Frantzen, J., Kumle, M., Kristensen, V., & Lund, E. (2008). Gene expression analysis in breast cancer epidedemiology: The Norwegian women and cancer postgenome cohort study. Breast Cancer Res, 10, 13–23.

Dumitrescu, R., & Cotarla, I. (2007). Understanding breast cancer risk: where do we stand in 2005. J Cell Mol Med, 9, 208–221.

Duran-Alvarez, J., Becerril-Bravo, E., Castro, V., Jimenez, B., & Gibson, R. (2009). The analysis of a group of acidic pharmaceuticals, carbamazepine, and potential endocrine disrupting compounds in wastewater irrigated soils by gas chromatography-mass spectrometry. Talanta, 78, 1159–1166.

Durando, M., Kass, L., Piva, J., Sonnenschein, C., Soto, A., Luque, E., & Munoz-de-Toro, M. (2007). Prenatal bisphenol A exposure induces preneoplastic lesions in the mammary gland in Wistar rats. Environ Health Persp, 115, 592–598.

Durmaz, E., Ozmert, E., Erkekoglu, P., Giray, B., Derman, O., Hincal, F., & Yurdakok, K. (2010). Plasma phthalate levels in pubertal gynecomastia. Pediatrics, 125, 122–129.

Dworkin, A., Huang, T., & Toland, A. (2009). Epigenetic alterations in the breast: implications for breast cancer detection, prognosis and treatment. Semin Cancer Biol, 19, 165–171.

E 

EBCTCG, E. B. C. T. C. G. (n.d.). Favorable and unfavorable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomized trials. Lancet, 355, 1757–1770.

El-Gamal, H., & Bennett, R. (2006). Increased breast cancer risk after radiotherapy for acne among women with skin cancer. J Am Acad Dermatol, 55, 981–989.

Engel, L., Hill, D., Hoppin, J., Lubin, J., Lynch, C., Pierce, J., … Alavanja, M. (2005). Pesticide use and breast cancer risk among farmers’ wives in the Agricultural Health Study. Am J Epidemiol, 161, 121–135.

Engel, S., Levy, M., Liu, Z., Kaplan, D., & Wolff, M. (2006). Xenobiotic phenols in early pregnancy amniotic fluid. Reprod Toxicol, 21, 110–2.

Enoch, R., Stanko, J., & Greiner, S. (2007). Mammary gland development as a sensitive end point after acute prenatal exposure to an atrazine metabolite mixture in female Long-Evans rats. Environ Health Persp, 115, 541–547.

Erren, T. C. (2001). A meta-analysis of epidemiologic studies of electric and magnetic fields and breast cancer in women and men. Bioelectromagnetics, (SUPPL. 5), S105–S119.

Ertl, H., & Butte, W. (2012). Bioaccessibility of pesticides and polychlorinated biphenyls from house dust: in-vitro methods and human exposure assessment.

Eskenazi, B., Fenster, L., Castorina, R., Marks, A. R., Sjödin, A., Rosas, L. G., … Bradman, A. (2011). A comparison of PBDE serum concentrations in Mexican and Mexican-American children living in California. Environ Health Persp, 119(10), 1442–1448.

European Commission (1985). Council Directive 85/469/EEC,  Council Directive prohibiting the use in livestock farming of certain substances having hormonal action. Official Journal No L 382, 31, 228–231.

Evans, G. W., & Kantrowitz, E. (2002). Socioeconomic status and health: the potential role of environmental risk exposure. Annu Rev Publ Health, 23, 303–331.

F 

Fan, W. Q., Yanase, T., Morinaga, H., Gondo, S., Okabe, T., Nomura, M., … Nawata, H. (2007). Atrazine-induced aromatase expression is SF-1 dependent: Implications for endocrine disruption in wildlife and reproductive cancers in humans. Environ Health Persp, 115(5), 720–727.

Fang, H., Tong, W., Branham, W. S., Moland, C. L., Dial, S. L., Hong, H., … Sheehan, D. M. (2003). Study of 202 Natural, Synthetic, and Environmental Chemicals for Binding to the Androgen Receptor. Chem Res Toxicol, 16(10), 1338–1358.

Fedrowitz, M., Kamino, K., & Loscher, W. (2004). Significant differences in the effects of magnetic field exposure on 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in two substrains of Sprague-Dawley rats. Cancer Res, 64, 243–251.

Felix, T., Hall, B. J., & S. Brodbelt, J. (1998). Determination of benzophenone-3 and metabolites in water and human urine by solid-phase microextraction and quadrupole ion trap GC-MS. Analytica Chimica Acta, 371(2-3), 195–203.

Fenton, S. (2006). Endocrine-disrupting compounds and mammary gland development: Early exposure and later life consequences. Endocrinology, 147, 18–24.

Fenton, S. E., Reed, C., & Newbold, R. R. (2012). Perinatal environmental exposures affect mammary development, function, and cancer risk in adulthood.  Annu Rev Pharmacol Toxicol 52, 455-479.

Fenton, S., Hamm, J., Birnbaum, L., & Youngblood, G. (2002). Persistent abnormalities in the rat mammary gland following gestational and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Sci, 67, 63–74.

Fernandez, M., Molina-Molina, J., Lopez-Espinosa, M., Freire, C., Campoy, C., Ibarluzea, J., … Olea, N. (2007). Biomonitoring of environmental estrogens in human tissues. Int J Hyg Environ Health, 210, 429–432.

Feychting, M., Forssen, U., Rutqvist, L., & Ahlbom, A. (1998). Magnetic fields and breast cancer in Swedish adults residing near high-voltage power lines. Epidemiology, 9, 392–397.

Figueiredo, J., Haile, R., Bernstein, L., & Malone, K. (2010). Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers. The WECARE study. Breast Cancer Res Treat, 120, 175–183.

Files, J. A., Ko, M. G., & Pruthi, S. (2011). Bioidentical hormone therapy. Mayo Clinic proceedings. Mayo Clinic, 86(7), 673–680, quiz 680. 

Florea, A.-M., Büsselberg, D., & Carpenter, D. (2012). Metals and disease. J Toxicol, art. no. 825354.

Florea, Ana-Maria, & Büsselberg, D. (2011). Metals and breast cancer: risk factors or healing agents? J Toxicol, art no. 159619.

Flynn-Evans, E., Stevens, R., Tabandeh, H., Schernhammer, E., & Lockley, S. (2009). Total visual blindness is protective against breast cancer. Cancer Causes Control, 20, 1753–1756.

Forastiere, F., Stafoggia, M., Tasco, C., Picciotto, S., Agabiti, N., Cesaroni, G., & Perucci, C. A. (2007). Socioeconomic status, particulate air pollution, and daily mortality: differential exposure or differential susceptibility. Am J Ind Med, 50(3), 208–216. 

Foster, P. (2005). Disruption of reproductive development in male rat offspring following in utero exposure to phthalate esters. Int J Androl, 29, 140–147.

Foster, W., Younglai, E., Boutross-Tadross, O., Hughes, C., & Wade, M. (2004). Mammary gland morphology in Sprague-Dawley rats following treatment with an organochlorine mixture in utero and neonatal genistein. Toxicol Sci, 77, 91–100.

Fournier, A., Berrino, F., & Clavel-Chapelon, F. (2008). Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Tr, 107(1), 103–111. 

Fournier, A., Fabre, A., Mesrine, S., Boutron-Ruault, M.-C., Berrino, F., & Clavel-Chapelon, F. (2008). Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer. J Clin Oncol, 26(8), 1260–1268. 

Frederiksen, H., Aksglaede, L., Sorensen, K., Skakkebaek, N. E., Juul, A., & Andersson, A.-M. (2011). Urinary excretion of phthalate metabolites in 129 healthy Danish children and adolescents: estimation of daily phthalate intake. Environ Res, 111(5), 656–663. 

Frederiksen, M., Thomsen, C., Froshaug, M., Vorkamp, K., Thomsen, M., Becher, G., & Knudsen, L. (2010). Polybrominated diphenyl ethers in paired samples of maternal and umbilical cord blood plasma and assocaitions with house dust in a Danish cohort. Int J Hygiene Environ Health, 13, 233–242.

Friis, R. (2012). Environmental Epidemiology. In Essentials of Environmental Health, (Sudbury, MA: Jones and Bartlett Learning, LLC), pp. 27–48.

Fritschi, L., Glass, D. C., Heyworth, J. S., Aronson, K., Girschik, J., Boyle, T., … Erren, T. C. (2011). Hypotheses for mechanisms linking shiftwork and cancer. Med Hypotheses, 77(3), 430–436.

Fromme, H., Diemer, J., Dietrich, S., Cyrys, J., Heinrich, J., Lang, W., … Twardella, D. (2008). Chemical and morphological properties of particulate matter (PM 10, PM 2.5) in school classrooms and outdoor air. Atmospheric Environ, 42, 6597–6605.

G 

Gaffield, M., Culwell, K., & Ravi, A. (2009). Oral contraceptives and family history of breast cancer. Contraception, 80, 372–380.

Gallagher, C. M., Chen, J. J., & Kovach, J. S. (2010). Environmental cadmium and breast cancer risk. Aging, 2(11), 804–814.

Gammon, M. D., Santella, R. M., & Neugut, A. I. (2002). Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts. Cancer Epidemiol Biomarkers Prev, 11, 677–685.

Gammon, M., & Santella, R. (n.d.). genetic susceptibility and breast cancer risk: an update from the Long Island breast cancer study project. Eur J Cancer, 44, 636–640.

Gao, S., Mioc, D., Anton, F., Yi, X., & Coleman, D.J. (2008). Online GIS services for mapping and sharing disease information. Int J Health Geog 7.

Gardner, K.M., Shu, X.O., Jin, F., Dai, Q., Ruan, Z., Thompson, S.J., Hussey, J.R., Gao, Y.T., & Zheng, W. (2002). Occupations and breast cancer risk among Chinese women in urban Shanghai. Am J Indust Med 42, 296–308.

Garvin, S., Ollinger, K., & Dabrosin, C. (2006). Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo. Sci Direct Cancer Lett, 231, 113–122.

Gauthier, E., Paoletti, X., & Clavel-Chapelon, F. (2004). Breast cancer risk associated with being treated for infertility: results from the French e3n cohort study. Hum Reprod, 19, 2216–2221.

Gee, R. H., Charles, A., Taylor, N., & Darbre, P. D. (2008). Oestrogenic and androgenic activity of triclosan in breast cancer cells. J Appl Toxicol, 28(1), 78–91.

Geens, T., Neels, H., & Covaci, A. (2012). Distribution of bisphenol-A, triclosan and n-nonylphenol in human adipose tissue, liver and brain. Chemosphere, 87(7), 796–802.

Gery, S., Virk, R., Chumakov, K., Yu, A., & Koeffler, H. (2007). The clock gene Per2 links the circadian system to the estrogen receptor. Oncogene, 26, 7916–7920.

Ghoussaini, M., & Pharoah, P. (2009). Polygenic susceptibility to breast cancer: current state-of-the-art. Future Oncol, 5, 689–701.

Gierthy, J., Arcaro, K., & Floyd, M. (1997). Assessment of PCB estrogenicity in a human breast cancer cell line. Chemosphere, 34, 1495–1505.

Ginsberg, G., Asgharian, B., Kimbell, J., Ultman, J., & Jarabek, A. (2008). Modeling approaches for estimating the dosimetry of inhaled toxicants in children. J Toxicol Environ Health, 71, 166–195.

Girgert, R., Emons, G., Hanf, V., & Grundker, C. (2009). Exposure of MCF-7 breast cancer cells to electromagnetic fields up-regulates the plasminogen activator system. Int J Gynecol Cancer, 19, 334–338.

Giusti, R., Iwamoto, K., & Hatch, E. (1995). Diethylstilbestrol revisited: A review of the long-term health effects. Annals Intern Med, 122, 778–788.

Glass, A., Lacey, J., Carreon, J., & Hoover, R. (2007). Breast cancer incidence, 1980-2006: Combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst, 99, 1152–1161.

Gofman, J. (1996). Preventing Breast Cancer: The Story of a Major, Proven, Preventable Cause of this Disease, 2nd ed. San Francisco: CNR Book Division, Committee.

Gofman, J. (1999). Radiation from Medical Procedures in the Pathogenesis of Cancer and Ischemic Heart Disease: Dose-responseSstudies with Physicians per 100,000 Population. San Francisco: CNR Book Division, Committee for Nuclear Responsibility.

Goldberg, Z. (2003). Radiation-induced effects in unirradiated cells: A review and implications in cancer. Int J Oncol, 21, 337–349.

Golden, R., & Kimbrough, R. (2009). Weight of evidence evaluation of potential human cancer risks from exposure to polychlorinated biphenyls: an update based on studies published since 2003. Cr Rev Toxicol, 39(4), 299–331. 

Golubicic, I., Borojevic, N., & Pavlovic, T. (2008). Risk factors for breast cancer: is ionizing radiation among them. J BUON, 13, 487–494.

Gomez, S. L., Quach, T., Horn-Ross, P. L., Pham, J. T., Cockburn, M., Chang, E. T., ... & Clarke, C. A. (2010). Hidden breast cancer disparities in Asian women: disaggregating incidence rates by ethnicity and migrant status. Journal Information, 100(S1).

Gooderham, N., Creton, S., Lauber, S., & Zhu, H. (2006). Mechanisms of action of the carcinogenic heterocyclic amine PhIP. Toxicol Lett, 168, 269–277.

Goodman, M., Shvetsov, Y., Wilkens, L., Franke, A., Le Marchand, L., Kakazu, K., … Kolonel, L. (2009). Urinary phytoestrogen excretion and postmenopausal breast cancer risk: the multiethnic cohort study. Cancer Prev Res, 2, 887–894.

Goodson, W. H., 3rd, Luciani, M. G., Sayeed, S. A., Jaffee, I. M., Moore, D. H., 2nd, & Dairkee, S. H. (2011). Activation of the mTOR pathway by low levels of xenoestrogens in breast epithelial cells from high-risk women. Carcinogenesis, 32(11), 1724–1733. 

Goto, H., Watanabe, T., Miyao, M., Fukuda, H., Sato, Y., & Oshida, Y. (2012). Cancer mortality among atomic bomb survivors exposed as children. Environ Health Prev Med, 17(3), 228–234.

Gotzsche, P., Hartling, O., Nielsen, M., Brodersen, J., & Jorgensen, K. (2009). Breast screening: the facts or maybe not. Br Med J, 338, 86.

Goyal, R., & Khare, M. (2009). Indoor-outdoor concentrations of RSPM in classroom of a naturally ventilated school building near an urban traffic roadway. Atmospheric Environ, 43, 6026–6038.

Gram, I., Braaten, T., Terry, P., Sasco, A., Adami, H., Lund, E., & Weiderpass, E. (2005). Breast cancer among women who started smoking as teenagers. Cancer Epidemiol Biomarkers Prev, 14, 61–66.

Graves, B. (2008). Integrative literature review: a review of literature related to geographical information systems, healthcare access, and health outcomes. Persp Health Info Manag, 5, 1–13.

Gray, L., Ryan, B., Hotchkiss, A., & Crofton, K. (2010). Rebuttal of “Flawed experimental design reveals the need for guidelines requiring appropriate positive controls in endocrine disruption research” by vom Saal. Toxicol Sci, 115, 614–620.

Grundy, A., & Aronson, K. J. (2012). Light exposure and melatonin among rotating shift nurses - Response. Cancer Epidemiol Biomarkers Prev, 21(3), 558.

Grundy, A., Richardson, H., Burstyn, I., Lohrisch, C., SenGupta, S.K., Lai, A.S., Lee, D., Spinelli, J.J., & Aronson, K.J. (2013). Increased risk of breast cancer associated with long-term shift work in Canada. Occup Environ Med, doi: 10.1136/oemed-2013-101482.

Grundy, A., Sanchez, M., Richardson, H., Tranmer, J., Borugian, M., Graham, C. H., & Aronson, K. J. (2009). Light intensity exposure, sleep duration, physical activity, and biomarkers of melatonin among rotating shift nurses. Chronobiol Int, 26(7), 1443–1461.

Guha, N., Kwan, M. L., Quesenberry, C. P., Jr, Weltzien, E. K., Castillo, A. L., & Caan, B. J. (2009). Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study. Breast Cancer Res and Tr, 118(2), 395–405. 

Guibout, C., Adjadj, E., Rubino, C., Shamsaldin, A., Grimaud, E., Hawkins, M., … De Vathaire, F. (2005). Malignant breast tumors after radiotherapy for a first cancer during childhood. J Clin Oncol, 23, 197–204.

Guillette, L., & Edwards, T. (2008). Environmental influences on fertility: can we learn lessons from studies of wildlife. Am Soc Reprod Med, 89, 21–24.

Gwinn, M., Whipkey, D., Tennant, L., & Weston, A. (2007). Gene expression profiling of di-n-butyl phthalate in normal human mammary epithelial cells. J Environ Pathol Toxicol Oncol, 26, 51–61.

Gyllenhammar, I., Glynn, A., Darnerud, P. O., Lignell, S., Van Delft, R., & Aune, M. (2012). 4-Nonylphenol and bisphenol A in Swedish food and exposure in Swedish nursing women. Environment Int, 43(1), 21–28.

H 

Hagmar, L., Wallin, E., Vessby, B., Jönsson, B. A., Bergman, Å., & Rylander, L. (2006). Intra-individual variations and time trends 1991-2001 in human serum levels of PCB, DDE and hexachlorobenzene. Chemosphere, 64(9), 1507–1513.

Haile, R., Thomas, D., McGuire, V., Felberg, A., John, E., Milne, R., … Ontario Cancer Genetics Network Investigators. (2006). BRCA1 and BRCA2 mutation carriers, oral contraceptive use and breast cancer before age 50. Cancer Epidemiol Biomarkers Prev, 15, 1863–1870.

Hanaoka, T., Yamamoto, S., Sobue, T., Sasaki, S., & Tsugane, S. (2005). Active and passive smoking and breast cancer risk in middle-aged Japanese women. Int J Cancer, 114, 317–322.

Hance, K., Anderson, W., Devesa, S., Young, H., & Levine, P. (2005). Trends in inflammatory breast carcinoma incidence and survival: The Surveillance, Epidemiology, and End Results Program at the National Cancer Institute. J Nat Cancer Inst, 95, 966–975.

Hande, M.P., Azizova, T.V., Geard, C.R., Burak, L.E., Mitchell, C.R., Khokhryakov, V.F., Vasilenko, E.K., & Brenner, D.J. (2003). Past exposure to densely ionizing radiation leaves a unique permanent signature in the genome. Am J Human Genet  72, 1162–1170.

Hankinson, S., Willett, W., Colditz, G., Hunter, D., Michaud, D., Deroo, B., … Pollak, M. (1998). Circulating concentrations of insulin-like growth factor 1 and risk of breast cancer. Lancet, 351, 1393–1396.

Hansen, J. (1999). Breast cancer risk among relatively young women employed in solvent-using industries. Am J Ind Med, 36, 43–47.

Hansen, J. (2000). Elevated risk for male breast cancer after occupational exposure to gasoline and vehicular combustion products. Am J Ind Med, 37, 349–352.

Hansen, Johnni, & Stevens, R. G. (2012). Case-control study of shift-work and breast cancer risk in Danish nurses: Impact of shift systems. Eur J Cancer, 48(11), 1722–1729. 

Hatakeyama, M., & Matsumura, F. (1999). Correlation between the activation of Neu tyrosine kinase and promotion of foci formation induced by selected organochlorine compounds in the MCF-7 model system. J Biochem Mol Toxicol, 13, 296–302.

Hayden, C., Roberts, M., & Benson, H. (1997). Systemic absorption of sunscreen after topical application. Lancet, 350, 853–864.

Hayes, T., Haston, K., Tsui, M., Hoang, A., Haeffele, C., & Vonk, A. (2003). Atrazine-induced hermaphoditism at 0.1 ppb in American leopard frogs (Rana pipiens): Laboratory and field evidence. Environ Health Persp, 111, 568–575.

Health Canada. (2008). Risk Assessment of Bisphenol A from food packaging applications. Bureau of Chemical Safety, Food Directorate, Health Products and Food Branch.

Heiss, G., Wallace, R., Anderson, G., Aragaki, A., Beresford, S., Brzyski, R., … Stefanick, M. (2008). Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. J Am Med Assoc, 299, 1036–1045.

Helferich, W., Andrade, J., & Hoagland, M. (2008). Phytoestrogens and breast cancer: a complex story. Inflammopharmacol, 16, 219–226.

Helmfrid, I., Berglund, M., Löfman, O., & Wingren, G. (2012). Health effects and exposure to polychlorinated biphenyls (PCBs) and metals in a contaminated community. Environ Int,, 44, 53–58. 

Hemminki, K., & Li, X. (2002). Cancer risks in second-generation immigrants to Sweden. Int J Cancer, 99, 229–237.

Hemminki, K., Koskinen, M., & Zhao, C. (2001). DNA adducts as a marker for cancer risk? International Journal of Cancer, 92(6), 923–925.

Heneweer, M., Muusse, M., Dingemans, M., De Jong, P., & Van den Burg, M. (2005). Co-culture of primary human mammary fibroblasts and MCF-7 cells as an in vitro breast cancer model. Toxicol Sci, 83, 257–263.

Henry, N. D., & Fair, P. A. (2011). Comparison of in vitro cytotoxicity, estrogenicity and anti-estrogenicity of triclosan, perfluorooctane sulfonate and perfluorooctanoic acid.  J Appl Toxicol, 10.1002/jat.1736.

Herbst, A. L., Ulfelder, H., & Poskanzer, D. C. (1971). Adenocarcinoma of the vagina: Association of maternal stilbestrol therapy with tumor appearance in young women. New England J Med, 284, 878–881.

Herbst, A., & Scully, R. (1970). Adenocarcinoma of the vagina in adolescence. A report of seven cases including six clear cell carcinomas (so-called mesonephromas). Cancer, 25, 745–757.

Heyes, G., Mill, A., & Charles, M. (2009). Mammography: oncogenecity at low doses. J Radiol Protect, 29, 123–132.

Hiatt, R., Haslam, S., & Osuch, J. (2009). The Breast Cancer and the Environment Research Centers: Transdisciplinary research on the role of the environment in breast cancer etiology. Environ Health Persp, 117, 1814–1822.

Highfield, L., Arthasarnprasit, J., Ottenweller, C.A., and Dasprez, A. (2011). Interactive web-based mapping: Bridging technology and data for health. IntJ of Health Geographics 10.

Hilakivi-Clarke, L., & De Assis, S. (2006). Fetal origins of breast cancer. Trends Endocrinol Metab, 17, 340–348.

Hildreth, N., Shore, R., & Dvoretsky, P. (1989). The risk of breast cancer after irradiation of the thymus in infancy. New England J Med, 1281–1284.

Hines, C., Nilsen Hopf, N., Deddens, J., Calafat, A., Silva, M., Grote, A., & Sammons, D. (2009). Urinary phthalate metabolite concentrations among workers in selected industries: A pilot biomonitoring study. Ann Occup Hyg, 53, 1–17.

Hines, E., Calafat, A., Silva, M., Mendola, P., & Fenton, S. (2009). Concentrations of phthalate metabolites in milk, urine, saliva, and serum of lactating North Carolina women. Environ Health Persp, 117, 86–92.

Hjartåker, A., Thoresen, M., Engeset, D., & Lund, E. (2010). Dairy consumption and calcium intake and risk of breast cancer in a prospective cohort: the Norwegian Women and Cancer study. Cancer Causes & Control, 21(11), 1875–1885. 

Hoffman, G. (2009). A Perspive on the scientific, philosophical, and policy dimensions of hormesis. Dose-Response, 7, 1–51.

Holmberg, L., & Anderson, H. (2004). HABITS (hormonal replacement therapy after breast cancer—is it safe?) trial stopped. Lancet, 363, 453–455.

Holtorf, K. (2009). The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy? Postgrad Med, 121(1), 73–85. 

Homburg, R., & Insler, V. (2002). Ovulation induction in Perspive. Hum Reprod Update, 8, 449–462.

Hong, Q., Wang, Y., Luo, X., Chen, S., Chen, J., Cai, M., … Mai, B. (2012). Occurrence of polychlorinated biphenyls (PCBs) together with sediment properties in the surface sediments of the Bering Sea, Chukchi Sea and Canada Basin. Chemosphere, 88(11), 1340–1345.

Honma, N., Takubo, K., Sawabe, M., Arai, T., Akiyama, F., Sakamoto, G., … Harada, N. (2007). Estrogen-metabolizing enzymes in breast cancers from women over the age of 80 years. J Clin Endocrinol Metab, 91, 607–613.

Hooning, M., Aleman, B., Hauptmann, M., Baaijens, M., Klijn, J., Noyon, R., … Van Leeuwen, F. (2007). Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer. J Clin Oncol, 34, 5561–5568.

Hoover, R. N., Hyer, M., Pfeiffer, R. M., Adam, E., Bond, B., Cheville, A. L., … Troisi, R. (2011). Adverse health outcomes in women exposed in utero to diethylstilbestrol. NE J Med 365(14), 1304–1314. 

Hortobagyi, G., De la Garza Salazar, J., Pritchard, K., Amadori, D., Haidinger, R., Hudis, C., … Albain, K. (2008). The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer, 6, 391–401.

Horwich, A., & Swerdlow, A. (2004). Secondary primary breast cancer after Hodgkin’s disease. Br J Cancer, 90, 294–298.

Houle, C., Ton, T., Clayton, N., Huff, J., Hong, H., & Sills, R. (2006). Frequent p53 and H-ras mutations in benzene- and ethylene oxide-induced mammary gland carcinomas from B6C3F1 mice. Toxicol Pathol, 34, 752–762.

Hovey, R. C., Coder, P. S., Wolf, J. C., Sielken Jr., R. L., Tisde, M. O., & Breckenridge, C. B. (2011). Quantitative assessment of mammary gland development in female long evans rats following in utero exposure to atrazine. Toxicol Sci, 119(2), 380–390.

Howe, G., & McLaughlin, J. (1996). Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study. Radiat Res, 145, 694–707.

Hoyer, A., Gerdes, A., Jorgensen, T., Rank, F., & Hartvig, H. (2002). Organochlorines, p53 mutations in relation to breast cancer risk and survival. A Danish cohort-nested case-controls study. Breast Cancer Res Treat, 71, 9–65.

Hoyer, A., Grandjean, P., Jorgensen, T., Brock, J., & Hartvig, H. (1998). Organochlorine exposure and risk of breast cancer. Lancet, 352, 1816–1820.

Hoyer, A., Jorgensen, T., Brock, J., & Grandjean, P. (2000). Organochlorine exposure and breast cancer survival. J Clin Epidemiol, 53, 323–330.

Høyer, A. P., Jørgensen, T., Rank, F., & Grandjean, P. (2001). Organochlorine exposures influence on breast cancer risk and survival according to estrogen receptor status: A Danish cohort-nested case-control study. BMC Cancer, 1.

Hsieh, C., Trichopoulos, D., Katsouyanni, K., & Yuasa, S. (1990). Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: Associations and interactions in an international case-control study. Int J Cancer, 46, 796–800.

Hsieh, T.-H., Tsai, C.-F., Hsu, C.-Y., Kuo, P.-L., Lee, J.-N., Chai, C.-Y., … Tsai, E.-M. (2012). Phthalates induce proliferation and invasiveness of estrogen receptor-negative breast cancer through the AhR/HDAC6/c-Myc signaling pathway. FASEB Journal, 26(2), 778–787.

Hua, W., Bennett, E., Maio, X., Metcalfe, C., & Letcher, R. (2006). Seasonality effects on pharmaceuticals and S-triazine herbicides in wastewater effluent and surface water from the Canadian side of the upper Detroit River. Environ Toxicol Chem, 25, 2356–2365.

Huang, J., & Mackillop, W. (2001). Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma. Cancer, 92, 532–536.

Huda, W., Schoepf, U. J., Abro, J. A., Mah, E., & Costello, P. (2011). Radiation-related cancer risks in a clinical patient population undergoing cardiac CT. Am J Roentgenol, 196(2), W159–165. 

Huff, J., Haseman, J., DeMarini, D., Eustis, S., Maronpot, R., Peters, A., … Jacobs, A. (1989). Multiple-site carcinogenicity of benzene in Fisher 344 rats and B6C3F1 mice. Environ Health Persp, 82, 125–163.

Hung, L.-J., Tsai, S.-S., Chen, P.-S., Yang, Y.-H., Liou, S.-H., Wu, T.-N., & Yang, C.-Y. (2012). Traffic air pollution and risk of death from breast cancer in Taiwan: Fine particulate matter (PM 2.5) as a proxy marker. Aerosol Air Qual Res, 12(2), 275–282.

Hunter, L., Gadbury, G., & Huang, Y. (2008). Atrazine exposure and breast cancer incidence: an ecologic study of Missouri counties. Toxicol Environ Chem, 90, 367–376.

Hwang, H., Park, E., Young, T., & Hammock, B. (2008). Occurrence of endocrine-disrupting chemicals in indoor dust. Sci Total Environ, 404, 26–35.